Sat, Sep 20, 2014, 3:09 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

St. Jude Medical Inc. Message Board

  • Pregu Pregu Jan 22, 2012 7:18 PM Flag

    Riata Summit

    There was a conference of physicians in Minneapolis about the Riata (STJ) lead. A summary is linked below, but I thought the most important part was

    "The attendees were polled again at the completion of the session and already high concerns were amplified. A higher proportion than earlier (58%) of those polled felt the Riata situation was a more serious problem than the Fidelis recall and 44% indicated that they had enough concern about the market released Durata lead that they would not be using this in the future. Despite HRS consensus recommendations to the contrary, 55% of attendees favored routine repeated fluoroscopic monitoring."

    http://www.forbes.com/sites/larryhusten/2012/01/21/guest-post-report-from-the-riata-icd-lead-summit/

    1. If 44% of physicians are not going to use Durata, because they are concerned, is this going to drive sales to BSX and MDT?
    2. Has STJ's historical advantage been their leads or their defib technology?
    3. Is it likely that there was a selection bias in the survey results (less than 63 doctors)? It seems like physicians that did not use Riata/Durata would not have bothered to come and that those physicians that did come would already have been concerned.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
STJ
62.24-1.22(-1.92%)Sep 19 4:03 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.